In estrogen receptor alpha (ERα) positive breast cancer cells, ERα stimulation promotes HSF1 activation through the MAPK/ERK pathway, in which the subsequent activation of the kinases MEK and ERK results in phosphorylation of HSF1 at serine 326 [104]. Here, ESR1 is linked to breast cancer.